Answers are grounded in this paper and cite their sources.
Figure.An 81-year-old man was diagnosed three years earlier with HER2 exon 20 insertion-mutated lung adenocarcinoma (cT4N3M1c, stage IVB).During chemotherapy, multiple new brain metastases were observed (Picture A and C), accompanied by the complete paralysis of his right upper extremity (manual muscle testing [MMT] grade 0).As a fifth-line therapy, zongertinib was initiated at 120 mg/day three days after the completion of stereotactic radiotherapy for the brain metastases (32.5 Gy in five fractions).His paralysis improved to MMT grade 3 within 12 days, and brain MRI demonstrated
No takes yet. Share an insight, caveat, or question.
Kobata et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: